Work

Late Breaking Abstract - Efficacy of high- and low-dose rilzabrutinib from a phase 2 study

Year: 2024

Type: conference-abstract

DOI: 10.1183/13993003.congress-2024.oa2774

Authors: Ian Douglas Pavord, Tanya M. Laidlaw, William Busse, Jorge Maspero, Tian Liu, Jessica Gereige, Leda Mannent, Renata Martincova

Institutions: University of Oxford, Brigham and Women's Hospital, Harvard University, University of Wisconsin–Madison, Sanofi (France), Sanofi (Czechia)

Language: English

Topic: Asthma and respiratory diseases

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4404104410

Cites:

Cited by:

Related to: 10